16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha (40665-93-8)

Identification
Name:	16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha
Synonyms:	16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha
CAS:	40665-93-8
Molecular Formula:	C₂₂H₂₉ClO₆
Molecular Weight:	0
InChI:	InChI=1/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16?,18-,19-,20+,21+/m1/s1
Molecular Structure:
Properties
Flash Point:	333.6°C
Boiling Point:	628°C at 760 mmHg
Density:	1.321g/cm³
Refractive index:	1.622
Flash Point:	333.6°C
Safety Data

Other Product

1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-6-[ (16S,19E)-19, 20-didehydro-16-(methoxycarbonyl)corynan-17-yl]-16-(methoxycarbony l)-19-methyl-, (19.alpha.)-
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
1/C16H15FN2O3S/c1-23(21,22)19-14-5-3-2-4-13(14)18-16(20)10-15(19)11-6-8-12(17)9-7-11/h2-9,15H,10H2,1H3,(H,18,20
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
1/C16H14ClNO3/c1-10-6-12(17)7-11(15(10)19)8-18-9-21-16(20)13-4-2-3-5-14(13)18/h2-7,19H,8-9H2,1H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C18H30O4/c1-4-5-6-7-15(19)13-16(20)10-8-14-9-11-17(21-2)18(12-14)22-3/h9,11-12,15-16,19-20H,4-8,10,13H2,1-3H3/t15-,16-/m0/s
1/C15H16N2O3/c1-10-5-3-4-6-13(10)19-9-12-8-17-11(2)7-14(18)16-15(17)20-12/h3-7,12H,8-9H2,1-2H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, (19-alpha,20-alpha)-, compd. with pyridinamine (1:1)
1/C18H32O3/c1-2-3-4-5-6-7-8-11-14-17(19)15-12-9-10-13-16-18(20)21/h11,14H,2-10,12-13,15-16H2,1H3,(H,20,21)/b14-11
1/C14H13N7O/c1-8-12(21-14(17)18-19-20-21)11(9-5-3-2-4-6-9)10(7-15)13(16)22-8/h2-6,11H,16H2,1H3,(H2,17,18,20
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H